Read + Share
Yanaihara N, Yoshino Y, Noguchi D, Tabata J, et al. Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to
PARP inhibitor via the CDK1/BRCA1 pathway. Gynecol Oncol 2022;168:83-91.
PMID: 36403366
|
 |
|
Yanaihara N, Yoshino Y, Noguchi D, Tabata J, et al. Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to
PARP inhibitor via the CDK1/BRCA1 pathway. Gynecol Oncol 2022;168:83-91.
PMID: 36403366
|
|
|
|